Image and pathological changes after microwave ablation of breast cancer: A pilot study

Zhou, Wenbin; Jiang, Yanni; Chen, Lin; Ling, Lijun; Liang, Mengdi; Pan, Hong; Wang, Siqi; Ding, Qiang; Li, Xiaoan; Wang, Shui

doi:10.1016/j.ejrad.2014.06.015

Cited by 36 publications

(33 citation statements)

References 28 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Our previous ablation-resection study [17] shows MWA of small breast cancer is feasible under general anaesthesia with about 4.5 min. The following study [18] shows 2 min MWA can cause an ablation zone with three diameters larger than 2 cm under local anaesthesia. To the best of knowledge, MWA of benign breast lumps has not been reported.…”

Section: Introductionmentioning

confidence: 74%

Ultrasound-guided microwave ablation: a promising tool in management of benign breast tumours

Zhou

Wang

et al. 2016

International Journal of Hyperthermia

Self Cite

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 74%

Ultrasound-guided microwave ablation: a promising tool in management of benign breast tumours

Zhou

Wang

et al. 2016

International Journal of Hyperthermia

Self Cite

View full text Add to dashboard Cite

show abstract

“…108,111,114,132,135 Reported complications following the percutaneous procedures included bruising, skin burns and necrosis, 91,103,113,114,136 as well as similar complications to those expected from open surgery, including seromas 91,115,143 and haematomas. 105,115,125,136,140,141,143 The lack of adequate follow-up data reported within these studies makes it difficult to assess the recurrence risk, with only one study of RFA reporting three local recurrences in 21 patients with invasive breast cancer at 60 months of follow up. 101 Long-term follow up is difficult as the majority of studies conducted are window studies, with percutaneous ablation followed by standard surgical excision.…”

Section: Minimally Invasive Percutaneous Surgerymentioning

confidence: 95%

Surgical treatment of nonpalpable primary invasive and in situ breast cancer

et al. 2015

View full text Add to dashboard Cite

Breast cancer is the most-common cancer among women worldwide, and over one-third of all cases diagnosed annually are nonpalpable at diagnosis. The increasingly widespread implementation of breast-screening programmes, combined with the use of advanced imaging modalities, such as magnetic resonance imaging (MRI), will further increase the numbers of patients diagnosed with this disease. The current standard management for nonpalpable breast cancer is localized surgical excision combined with axillary staging, using sentinel-lymph-node biopsy in the clinically and radiologically normal axilla. Wire-guided localization (WGL) during mammography is a method that was developed over 40 years ago to enable lesion localization preoperatively; this technique became the standard of care in the absence of a better alternative. Over the past 20 years, however, other technologies have been developed as alternatives to WGL in order to overcome the technical and outcome-related limitations of this technique. This Review discusses the techniques available for the surgical management of nonpalpable breast cancer; we describe their advantages and disadvantages, and highlight future directions for the development of new technologies.

show abstract

“…MWA has also been trialled to treat solid tumours in multiple other organs including the bone, breast, abdominal wall and bladder [8,9,[88][89][90][91][92][93][94][95]. Published reports have been very scarce, and the technique has not been widely used in these organs, as in the liver, kidney and lung, but the preliminary results were encouraging.…”

Section: Mwa In Other Organsmentioning

confidence: 99%

“…For breast cancer therapy, MWA has fewer published reports than RFA. The only two trials were from Zhou et al [9,90] in China; they showed that 97.3% of tumours achieved complete coagulation with cancer up to 3.0 cm in the largest diameter in 41 patients and 100% technique success was achieved in 12 patients with cancer up to 2.0 cm in the largest diameter. By combining MWA with neoadjuvant chemotherapy, an alternative method was made available for small breast cancer patients without surgical options, but the long-term outcomes need to be determined in the future.…”

Section: Mwa In Other Organsmentioning

confidence: 99%

“…The microwave technique was first adopted for tumour ablation by Saitsu et al [2] from Japan to treat small liver cancers and has achieved wider application over the past two decades, particularly in China. Although radiofrequency ablation (RFA) remains the most widely used ablation technique worldwide, with the improvement of microwave ablation (MWA) equipment and treatment strategies, now MWA has expanded its clinical applications in many institutions in Far East countries and parts of Western countries, from small hepatocellular carcinomas (HCC) to large liver cancers greater than 5 cm and multiple other solid tumours including those in the kidney, adrenal, spleen, thyroid, lung, breast, abdominal wall and uterus [3][4][5][6][7][8][9][10]. The MWA technique has developed rapidly over the past decade in China and has been used clinically in more than 500 hospitals in China.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Status and advancement of microwave ablation in China

Liang

2016

International Journal of Hyperthermia

View full text Add to dashboard Cite

Tumour ablation is defined as the direct application of chemical or thermal therapy to eradicate or substantially destroy a tumour. Currently, minimally invasive ablation techniques are available for the local destruction of focal tumours in multiple organ sites. Microwave ablation (MWA) is premised on the biological response of solid tumours to tissue hyperthermia, and it is a relatively low-risk procedure. Due to several advantages of MWA, including higher thermal efficiency, higher capability for coagulating blood vessels, faster ablation time and the simultaneous application of multiple antennae, MWA could be a promising minimally invasive ablation technique for the treatment of solid tumours. Therefore, the use of MWA has developed rapidly in China during the last decade. Many successful studies have been performed, and widespread use has been achieved for multiple types of tumours in China, especially for liver cancer. This review will describe the state-of-the-art of MWA in China, including the development of MWA equipment and its application in the treatment of multiple types of tumours.

show abstract

Image and pathological changes after microwave ablation of breast cancer: A pilot study

Cited by 36 publications

References 28 publications

Ultrasound-guided microwave ablation: a promising tool in management of benign breast tumours

Ultrasound-guided microwave ablation: a promising tool in management of benign breast tumours

Surgical treatment of nonpalpable primary invasive and in situ breast cancer

Status and advancement of microwave ablation in China

Contact Info

Product

Resources

About